Episode 134: Erik Gordon on SPACs, plus Covid-19 vaccines, & Biogen's case in Alzheimer's

from The Readout Loud · host STAT

Who's voice rings loudest at the FDA? Is it wise to give hedge funds a blank check? And how will the Biogen saga end?

Episode metadata supplied by the publisher feed · Published Oct 22, 2020

Embed this episode

Attribution link and audio player

NOW PLAYING

Episode 134: Erik Gordon on SPACs, plus Covid-19 vaccines, & Biogen's case in Alzheimer's

0:00 24:59

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Similar Episodes

No similar episodes found.

No similar podcasts found.

This episode is 24 minutes long.

This episode was published on October 22, 2020.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!